Manulife (Manufacturers Life Insurance)’s CARGO Therapeutics CRGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-40,849
Closed -$168K 2921
2025
Q2
$168K Buy
40,849
+57
+0.1% +$244 ﹤0.01% 2620
2025
Q1
$166K Sell
40,792
-93,665
-70% -$627K ﹤0.01% 2547
2024
Q4
$1.94M Sell
134,457
-1,694
-1% -$30.7K ﹤0.01% 1574
2024
Q3
$2.51M Sell
136,151
-22,868
-14% -$409K ﹤0.01% 1474
2024
Q2
$2.61M Buy
159,019
+26,808
+20% +$510K ﹤0.01% 1418
2024
Q1
$2.95M Buy
132,211
+54,015
+69% +$1.29M ﹤0.01% 1378
2023
Q4
$1.81M Buy
+78,196
New +$1.33M ﹤0.01% 1499

Other funds holding CRGX

Manulife (Manufacturers Life Insurance)'s CRGX Position: Q3 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 40,849 shares — an estimated $168K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $2.95M in Q1 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 40,849 CARGO Therapeutics shares in Q3 2025, an estimated $168K.
  • Manulife (Manufacturers Life Insurance) first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s CARGO Therapeutics position peaked at $2.95M in Q1 2024.
  • 1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2025, filed 14 Nov 2025.